NASHVILLE, Tenn.--(BUSINESS WIRE)--Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting clinical trials, is pleased to announce that Ishwaria ...

Dr. Subbiah has served as the Principal Investigator in over 100 phase I/II trials and co-investigator in over 200 clinical trials and is known for his leadership in several first-in-human and ...

For Varadarajan Subbiah, MD, focusing on daily actions, such as using huddle boards and regular communication to stay aware of factors impacting patient care, is a top priority. In December, Dr.

Shanmuga Subbiah, MD is the medical director of the Emanate Health Cancer Center and a hematologist/oncologist on the Emanate Health Medical Center and Emanate Health ...

Shanmuga Subbiah, MD is the medical director of the Emanate Health Cancer Center and a hematologist/oncologist on the Emanate Health Medical Center and Emanate Health ...

“Participating in a clinical trial is the first step in fighting cancer, and we must ensure that more patients – especially underserved populations – can access these treatment options,” said Howard A ...

A transformative and experienced leader in cancer clinical trial design and implementation, Dr. Subbiah comes to SCRI from the University of Texas MD Anderson Cancer Center where he was an Associate ...